Status:
UNKNOWN
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Neuroendocrine Cancer
Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Thermal therapy (hyperthermia, or heat) increases chemotherapy cancer cell kill. By itself, thermal therapy can also kill cancer cells. Whole body thermal therapy is a systemic treatment; whole-body f...
Detailed Description
The treatment cycle begins with 6 hours of intravenous (IV) hydration followed by an infusion of the anti-cancer drug, Cisplatin. In addition, at the beginning of this treatment, you will begin low-do...
Eligibility Criteria
Inclusion
- \- Any patient with inoperable or metastatic small-cell lung cancer, neuroendocrine cancer (any organ), gastric cancer, of lung cancer are eligible for protocol treatment.
- However the patient:
- Must not have metastasis to the brain
- Must be able to achieve positive results on preliminary tests
- Must have a good ECOG performance status
Exclusion
- Metastasis to the brain
- Poor results on preliminary physiological tests
- a Poor ECOG performance status score
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00178698
Start Date
July 1 2002
End Date
June 1 2014
Last Update
March 3 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030